between 1973 and 1982 , 110 patients with advanced hodgkin 's disease who had had disease progression while receiving mopp ( mechlorethamine , vincristine , procarbazine , and prednisone ) chemotherapy or a relapse after a mopp-induced complete remission were treated with either abvd ( doxorubicin , bleomycin , vinblastine , and dacarbazine ) ( 58 patients ) or b-cave ( bleomycin , lomustine , doxorubicin , and vinblastine ) ( 52 patients ) chemotherapy in concurrent nonrandomized trials .
C0019829
hodgkin 's disease
C0010927
dacarbazine